1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Biological Therapy Analysis & Statistics, April 2017 (p3)

Biological Therapy Analysis & Statistics, April 2017 (p3)

24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Publishers

61-90 of about 900 reports

Purchase Reports From Reputable Market Research Publishers

Leber Congenital Amaurosis - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • April 2017
  • by Global Markets Direct

Leber Congenital Amaurosis - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Leber Congenital Amaurosis – Pipeline Review, H1 2017, ...

  • Industries : Therapy
  • Countries : United States

Neutropenia - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • April 2017
  • by Global Markets Direct

Neutropenia - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Neutropenia – Pipeline Review, H1 2017, provides an overview of the ...

  • Industries : Therapy, Pharmaceutical
  • Countries : United States

Liver Fibrosis - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • April 2017
  • by Global Markets Direct

Liver Fibrosis - Pipeline Review, H1 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Liver Fibrosis - Pipeline Review, H1 2017, provides an overview of ...

  • Industries : Pharmaceutical, Pathology, Therapy
  • Countries : United States, World

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • March 2017
  • by Global Markets Direct

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) ...

  • Industries : Cancer, Pathology
  • Countries : United States

Myocardial Infarction - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • March 2017
  • by Global Markets Direct

Myocardial Infarction - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Myocardial Infarction – Pipeline Review, H1 2017, provides ...

  • Industries : Chronic Disease, Pathology
  • Countries : United States, World

Nasopharyngeal Cancer - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • March 2017
  • by Global Markets Direct

Nasopharyngeal Cancer - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Nasopharyngeal Cancer – Pipeline Review, H1 2017, provides ...

  • Industries : Cancer, Pathology, Therapy
  • Countries : United States

Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • March 2017
  • by Global Markets Direct

Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Juvenile Macular Degeneration – ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Healthcare
  • Countries : United States

Epstein–Barr Virus (HHV-4) Infections - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • March 2017
  • by Global Markets Direct

Epstein–Barr Virus (HHV-4) Infections - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Epstein–Barr Virus (HHV-4) Infections – ...

  • Industries : Pathology
  • Countries : United States, World, United Kingdom

B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • March 2017
  • by Global Markets Direct

B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide B-Cell Chronic Lymphocytic Leukemia – Pipeline ...

  • Industries : Cancer, Pathology
  • Countries : United States

Bronchopulmonary Dysplasia - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • March 2017
  • by Global Markets Direct

Bronchopulmonary Dysplasia - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bronchopulmonary Dysplasia – Pipeline Review, H1 2017, ...

  • Industries : Therapy, Chronic Disease
  • Countries : United States

Duchenne Muscular Dystrophy - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • March 2017
  • by Global Markets Direct

Duchenne Muscular Dystrophy - Pipeline Review, H1 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Duchenne Muscular Dystrophy - Pipeline Review, H1 2017, ...

  • Industries : Pathology, Mental Health, Therapy, Pharmaceutical
  • Countries : United States

Thalassemia - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • March 2017
  • by Global Markets Direct

Thalassemia - Pipeline Review, H1 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Thalassemia - Pipeline Review, H1 2017, provides an overview of the ...

  • Industries : Pathology, Healthcare
  • Countries : United States

Liver Cirrhosis - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • March 2017
  • by Global Markets Direct

Liver Cirrhosis - Pipeline Review, H1 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Liver Cirrhosis - Pipeline Review, H1 2017, provides an overview ...

  • Industries : Pathology
  • Countries : United States

Bone Marrow Transplant Rejection - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • March 2017
  • by Global Markets Direct

Bone Marrow Transplant Rejection - Pipeline Review, H1 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Bone Marrow Transplant Rejection - Pipeline Review, ...

  • Industries : Healthcare, Blood Supply, Tissue Banking and Transplantation, Health Facility, Therapy
  • Countries : United States

Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • March 2017
  • by Global Markets Direct

Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Congestive Heart Failure (Heart Failure) ...

  • Industries : Chronic Disease, Pathology
  • Countries : United States

Batten Disease - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • March 2017
  • by Global Markets Direct

Batten Disease - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Batten Disease - Pipeline Review, H1 2017, provides an overview of ...

  • Industries : Mental Health, Pathology, Therapy
  • Countries : United States

Primary Immune Deficiency (PID) - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • March 2017
  • by Global Markets Direct

Primary Immune Deficiency (PID) - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Primary Immune Deficiency (PID) – Pipeline Review, ...

  • Industries : Pathology, Healthcare, Therapy
  • Countries : United States, World

Osteoarthritis - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • March 2017
  • by Global Markets Direct

Osteoarthritis - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteoarthritis – Pipeline Review, H1 2017, provides an overview of ...

  • Industries : Chronic Disease, Pathology
  • Countries : United States, World

Chemotherapy Induced Neutropenia - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • March 2017
  • by Global Markets Direct

Chemotherapy Induced Neutropenia - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chemotherapy Induced Neutropenia – Pipeline Review, ...

  • Industries : Therapy, Oncology
  • Countries : United States

Crigler-Najjar Syndrome - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • March 2017
  • by Global Markets Direct

Crigler-Najjar Syndrome - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Crigler-Najjar Syndrome – Pipeline Review, H1 2017, provides ...

  • Industries : Biological Therapy
  • Countries : World, United States

Traumatic Brain Injury - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • February 2017
  • by Global Markets Direct

Traumatic Brain Injury - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Traumatic Brain Injury – Pipeline Review, H1 2017, provides ...

  • Industries : Mental Health, Pathology
  • Countries : United States

Degenerative Disc Disease - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • February 2017
  • by Global Markets Direct

Degenerative Disc Disease - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Degenerative Disc Disease – Pipeline Review, H1 2017, ...

  • Industries : Therapy, Pathology, Pharmaceutical, Biological Therapy
  • Countries : United States

House Dust Mite Allergy - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • February 2017
  • by Global Markets Direct

House Dust Mite Allergy - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide House Dust Mite Allergy – Pipeline Review, H1 2017, provides ...

  • Industries : OTC, Pharmaceutical, Chronic Disease
  • Countries : Japan, World, North America, United States, Europe

Pneumonia Treatment Drugs Industry Forecasts - China Focus

  • $ 1800
  • Industry report
  • May 2017
  • by Asia Market Information & Development Company

This study focuses on China’s Pneumonia Treatment Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities ...

  • Industries : Therapy, Pharmaceutical
  • Countries : China

Blood Disease Drugs Industry Forecasts - China Focus

  • $ 1800
  • Industry report
  • May 2017
  • by Asia Market Information & Development Company

This study focuses on China’s Blood Disease Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities ...

  • Industries : Pathology
  • Countries : China

Skin Cancer Treatment Drugs Industry Forecasts - China Focus

  • $ 1800
  • Industry report
  • April 2017
  • by Asia Market Information & Development Company

This study focuses on China’s Skin Cancer Treatment Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities ...

  • Industries : Cancer, Therapy, Pathology, Oncology
  • Countries : China

Therapy Industry Forecasts - China Focus

  • $ 1800
  • Industry report
  • March 2017
  • by Asia Market Information & Development Company

This study focuses on China’s Therapy industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising ...

  • Industries : Healthcare
  • Countries : China

2017-2021 US Cell Surface Marker Testing Market: Competitive Strategies, Country Forecasts, Innovative Technologies, Emerging Opportunities

  • $ 1450
  • Industry report
  • March 2017
  • by Venture Planning Group

Complete report $2,050.  DataPack (test volumes, sales forecasts, supplier shares) $1,450. Rationale The use of surface marker identification and classification of cells is spreading beyond lymphocytes ...

  • Industries : Biological Therapy
  • Countries : United States

2017 US Cell Surface Marker Testing Market: Future Horizons and Growth Strategies--Supplier Shares, Competitive Intelligence, Emerging Opportunities

  • $ 1450
  • Industry report
  • March 2017
  • by Venture Planning Group

Complete report $2,250.  DataPack (test volumes, sales forecasts, supplier shares) $1,450. Rationale The use of surface marker identification and classification of cells is spreading beyond lymphocytes ...

  • Industries : Biological Therapy
  • Countries : United States

Asia Pacific Stem Cell Market Forecast 2017-2025

  • $ 1238
  • Industry report
  • April 2017
  • by Inkwood Research

KEY FINDINGS The Asia Pacific Stem cell market is estimated at $10319 million in the year 2016 and expected to reach $83147 million in the year 2025 at a CAGR of 26.23% during the forecast period 2017-2025.The ...

  • Industries : Biological Therapy
  • Countries : Asia

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.